Evidence map›Paper›PMID 31632269›Full record

ArticleFrontiers in pharmacology2019

The Immune-Modulator Pidotimod Affects the Metabolic Profile of Exhaled Breath Condensate in Bronchiectatic Patients: A Metabolomics Pilot Study.

Maria D'Amato, Debora Paris, Antonio Molino, Paola Cuomo, Andrea Fulgione, Nunzia Sorrentino, Letizia Palomba, Mauro Maniscalco, Andrea Motta

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. From Legacy to Innovation: Pidotimod's Expanding Therapeutic Horizon.Mediterranean journal of hematology and infectious diseases · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Maria D'AmatoDivision of Pneumology, Department of Respiratory Diseases, University of Naples Federico II, AORN dei Colli-Monaldi Hospital, Naples, Italy.
Debora ParisInstitute of Biomolecular Chemistry, National Research Council, Pozzuoli, Italy.
Antonio MolinoDivision of Pneumology, Department of Respiratory Diseases, University of Naples Federico II, AORN dei Colli-Monaldi Hospital, Naples, Italy.
Paola CuomoInstitute of Biomolecular Chemistry, National Research Council, Pozzuoli, Italy.
Andrea FulgioneDepartment of Agriculture, University of Naples Federico II, Portici, Italy.
Nunzia SorrentinoDivision of Pneumology, Department of Respiratory Diseases, University of Naples Federico II, AORN dei Colli-Monaldi Hospital, Naples, Italy.
Letizia PalombaDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.
Mauro ManiscalcoPulmonary Rehabilitation Unit, ICS Maugeri SPA, IRCCS, Telese Terme, Italy.
Andrea MottaInstitute of Biomolecular Chemistry, National Research Council, Pozzuoli, Italy.
National Research Council · ITUniversity of Naples Federico II · ITIstituti Clinici Scientifici Maugeri · ITOspedale Monaldi · ITUniversity of Urbino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersbronchiectasisdisabilityexhaledmetabolomicsNMRoutcomerehabilitation

Identifiers

PMID31632269
PMCPMC6785784
OpenAlexW2970968501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.